DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $615,000 | -51.7% | 30,485 | -10.7% | 0.03% | -50.0% |
| Q2 2021 | $1,274,000 | +45.1% | 34,146 | -0.5% | 0.07% | +36.0% |
| Q1 2021 | $878,000 | +21.9% | 34,319 | +5.0% | 0.05% | -3.8% |
| Q4 2020 | $720,000 | -61.9% | 32,676 | -68.9% | 0.05% | -14.8% |
| Q3 2020 | $1,889,000 | +13.5% | 104,990 | +60.3% | 0.06% | +41.9% |
| Q2 2020 | $1,664,000 | +5.0% | 65,494 | -24.1% | 0.04% | +2.4% |
| Q1 2020 | $1,585,000 | -55.2% | 86,289 | -46.2% | 0.04% | -16.0% |
| Q4 2019 | $3,535,000 | +600.0% | 160,452 | +356.4% | 0.05% | +733.3% |
| Q3 2019 | $505,000 | – | 35,155 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |